Drug-induced supersensitivity psychosis revisited: characteristics of relapse in treatment-compliant patients
about
Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant SchizophreniaUpdate on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor AntagonismSupersensitivity psychosis and its response to asenapine in a patient with delusional disorderDopamine supersensitivity psychosis and dopamine partial agonist: a retrospective survey of failure of switching to aripiprazole in schizophreniaThe Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics.A 20-Year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia.Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive Review.Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy.Late-Onset Mania in a Patient with Movement Disorder and Basal Ganglia Calcifications: A Challenge for Diagnosis and Treatment.Switching to aripiprazole for the treatment of residual mutism resulted in distinct clinical courses in two catatonic schizophrenia casesDopamine supersensitivity psychosis in schizophrenia: Concepts and implications in clinical practice.Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study.
P2860
Q26773403-E4EB372B-A58C-4936-82CC-1416CAFC3B18Q28084069-34843F93-A46E-4868-8EF1-0308E1C68742Q34588453-CECE8123-2F50-4174-8341-E82EE9759975Q35186503-CEC9CA89-7FC9-4155-8531-517A4DE296C9Q38570636-16C11BA0-A5F3-4379-9B34-9B8DD7BCFB33Q38708602-29333170-7C7A-46F8-A0F8-C5D7D70DBCEDQ38855787-4FE21D8E-60A9-416E-9407-89A0F29D4B00Q39396657-2E7D0762-D0A8-48E5-8382-0EEA7E9E2C1CQ41150179-304041AB-D6F0-448A-A1A7-01ADAB9F6550Q42252687-2BD4ED99-4492-4494-A9B4-0A690118E789Q47618934-1CC0385D-2027-40FF-8F86-F030C46D44BAQ52652401-4D12473E-DEBC-4C3C-9509-E73DA5C606A6
P2860
Drug-induced supersensitivity psychosis revisited: characteristics of relapse in treatment-compliant patients
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Drug-induced supersensitivity ...... n treatment-compliant patients
@ast
Drug-induced supersensitivity ...... n treatment-compliant patients
@en
Drug-induced supersensitivity ...... n treatment-compliant patients
@nl
type
label
Drug-induced supersensitivity ...... n treatment-compliant patients
@ast
Drug-induced supersensitivity ...... n treatment-compliant patients
@en
Drug-induced supersensitivity ...... n treatment-compliant patients
@nl
prefLabel
Drug-induced supersensitivity ...... n treatment-compliant patients
@ast
Drug-induced supersensitivity ...... n treatment-compliant patients
@en
Drug-induced supersensitivity ...... n treatment-compliant patients
@nl
P2860
P3181
P356
P1476
Drug-induced supersensitivity ...... n treatment-compliant patients
@en
P2093
Paul Fallon
Serdar Dursun
P2860
P3181
P356
10.1177/2045125311431105
P407
P50
P577
2012-02-01T00:00:00Z